Gian-Paolo Dotto

Last updated

Gian-Paolo Dotto is an Italian researcher and professor at Massachusetts General Hospital, Boston (MA) and the University of Lausanne. [1] [2] His research focuses on genetic and epigenetic determinants of Cancer susceptibility and pre-malignant to malignant conversion. [3]

Contents

Career

Dotto obtained his medical degree in 1979 from the University of Turin, Italy and attained his PhD in Genetics at The Rockefeller University, New York, in 1983. In 1984, he pursued postdoctoral work at the Whitehead Institute/MIT in Cambridge Massachusetts. In 1987, he moved on to fulfill a position as assistant professor of Pathology at Yale University, New Haven, Connecticut. [4]

In 1992, Dotto obtained a position of Associate Professor in the Cutaneous Biology Research Center (CBRC) at Massachusetts General Hospital and Harvard Medical School. [2] In 2000 he obtained a full professorship in Dermatology at Harvard Medical School. Dotto became affiliated to the University of Lausanne (UNIL) as a Professor of Biochemistry in 2002, while maintaining a principal investigator position and active research laboratory at MGH. [1] He directed the UNIL PhD program in Cancer and Immunology (2007-2019) and became an emeritus professor at UNIL in 2021. [5] [1] In 2016, he founded the International Cancer Prevention Institute (ICPI), of which he is the president. [6] He is director of the Skin Aging and Cancer Prevention laboratory at CBRC/MGH and of the Head/Neck Personalized Cancer Prevention Program at Centre Hospitalier Universitaire Vaudois (CHUV) and UNIL. [7]

Research

During his doctoral studies in bacteriophage genetics with Norton Zinder at the Rockefeller University, he probed into control of DNA replication through specific DNA sequences and proteins. [8] During his postdoctoral training with Robert Weinberg at the Whitehead Institute/MIT, Dotto was among the first to establish that multistep carcinogenesis results from an interplay between specific genetic alterations and the tumor microenvironment. [9]

Research in his laboratory focuses on the role of intracellular and extracellular communication in early steps of cancer development with skin as model system. [10] His group studies how alterations in key developmental (Notch/CSL) and hormonal (androgens) signaling pathways impinge on cancer cells of origin and intermingled cancer associated fibroblasts (CAFs) and the expansion and multifocality of cancer lesions over time (field cancerization). [11] Additionally, his group focuses on genetic and epigenetic determinants of differences observed in cancer susceptibility across gender and race. [12] [4]

Distinctions and awards

Dotto is a member of the European Molecular Biology Organization, the Academia Europaea , the German National Academy of Sciences Leopoldina , and a former Fellow of the Jane Coffin Childs Memorial Fund for Medical Research. [13] He has received a lifetime achievement award in 2020 from the University of Lausanne. [14] In 2013, he was the recipient of a European Research Council Advanced Investigator Grant, and in 2015, he was awarded the Jurg Tschopp Award for Excellence in Biological Sciences in 2015 from the University of Lausanne (Faculty Biology and Medicine). [15]

Outreach

In 2016, Dotto founded (and is director of) the international Cancer Prevention Institute together with Cathrin Brisken. [6] Through this institute he assembles educators, policy makers and the general public to foster joint interdisciplinary efforts focused on cancer prevention. He has organized courses and workshops focused on cancer prevention [16] [17] and installed a collaborative PhD program focusing on cancer prevention (Marie Skłodowska-Curie Actions (MSCA) Innovative Training Network (ITN)) in 2019. [18]

Dotto has been contributing articles for L'Osservatore Romano and the Science and Society section of EMBO Reports . Additionally, he has dedicated a website to promote dialogue between natural sciences and humanities, and has recently published a book entitled "Death and Resurrection: An experiment in progress". [19] [20]

Related Research Articles

<span class="mw-page-title-main">University of Lausanne</span> University in Lausanne, Switzerland

The University of Lausanne in Lausanne, Switzerland was founded in 1537 as a school of Protestant theology, before being made a university in 1890. The university is the second oldest in Switzerland, and one of the oldest universities in the world to be in continuous operation. As of fall 2017, about 15,000 students and 3,300 employees studied and worked at the university. Approximately 1,500 international students attend the university, which has a wide curriculum including exchange programs with other universities.

<span class="mw-page-title-main">Rockefeller University</span> Biomedical research university in New York City, US

The Rockefeller University is a private biomedical research and graduate-only university in New York City, New York. It focuses primarily on the biological and medical sciences and provides doctoral and postdoctoral education. It is classified as a "Special Focus – Research Institution". Rockefeller is the oldest biomedical research institute in the United States.

Norton David Zinder was an American biologist famous for his discovery of genetic transduction. Zinder was born in New York City, received his A.B. from Columbia University in 1947, Ph.D. from the University of Wisconsin–Madison in 1952, and became a member of the National Academy of Sciences in 1969. He led a lab at Rockefeller University until shortly before his death.

Suzanne Cory is an Australian molecular biologist. She has worked on the genetics of the immune system and cancer and has lobbied her country to invest in science. She is married to fellow scientist Jerry Adams, also a WEHI scientist, whom she met while studying for her PhD at the University of Cambridge, England.

<span class="mw-page-title-main">HEC Lausanne</span>

HEC Lausanne, also called the Faculty of Business and Economics of the University of Lausanne, is the affiliated business school of the University of Lausanne. Since 1911, HEC Lausanne has been developing teaching and research in the field of business and economics. HEC Lausanne offers Bachelor’s, Master’s, and PhD degrees, as well as executive education, professional certification, and professional development programs, including a part-time Executive MBA, short, open courses, and tailor-made programs for organizations.

Tyler Jacks is a David H. Koch Professor of Biology at the Massachusetts Institute of Technology (MIT), a long-time HHMI investigator, and Founding Director of the David H. Koch Institute for Integrative Cancer Research, which brings together biologists and engineers to improve detection, diagnosis, and treatment of cancer. Dr. Jacks is a member of the board of directors of Thermo Fisher Scientific and Amgen, two of the major biotechnology corporations in the world. He is the President of Break Through Cancer, a foundation dedicated to supporting multi-institutional teams of researchers focused on finding solutions to some of the most difficult to treat cancers. He is also a member of the Board of Overseers, the larger of two governing boards of Harvard University.

<span class="mw-page-title-main">Harvey Lodish</span> American cell biologist, born 1941

Harvey Franklin Lodish is a molecular and cell biologist, professor at the Massachusetts Institute of Technology (MIT), Founding Member of the Whitehead Institute for Biomedical Research, and lead author of the textbook Molecular Cell Biology. Lodish's research focused on cell surface proteins and other important areas at the interface between molecular cell biology and medicine.

<span class="mw-page-title-main">Lausanne University Hospital</span> Hospital in Vaud, Switzerland

The Lausanne University Hospital, in Lausanne, is one of the five university hospitals in Switzerland.

Richard Olding Hynes is a British biologist, a Howard Hughes Medical Institute Investigator, and the Daniel K. Ludwig Professor for Cancer Research at the Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT). His research focuses on cell adhesion and the interactions between cells and the extracellular matrix, with a particular interest in understanding molecular mechanisms of cancer metastasis. He is well known as a co-discoverer of fibronectin molecules, a discovery that has been listed by Thomson Scientific ScienceWatch as a Nobel Prize candidate.

<span class="mw-page-title-main">Hans Clevers</span> Dutch molecular genetics and stem cell researcher

Johannes (Hans) Carolus Clevers is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022. Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research and at the Princess Máxima Center; he remained as an advisor and guest scientist or visiting researcher to both groups. He is also a Professor in Molecular Genetics at the University of Utrecht.

<span class="mw-page-title-main">Lausanne campus</span>

The Lausanne campus or Dorigny university campus is a large area in Switzerland where the University of Lausanne (UNIL), the École polytechnique fédérale de Lausanne (EPFL) and several other institutions are located. It is in Dorigny, towards the west of Lausanne, on the shores of Lake Geneva. The site is about 2.2 kilometres wide and 31,000 people study and work there.

<span class="mw-page-title-main">Swiss Cancer Centre</span> Alliance of academic and clinical institutions

The Swiss Cancer Center - Leman (SCCL) is an alliance against cancer forged between several academic and clinical institutions: the University Hospital of Lausnne (CHUV), the University Hospitals of Geneva (HUG), the University of Lausanne, the University of Geneva and the Swiss Federal Institute of Technology Lausanne (EPFL), as well as privileged partners.

Susan M. Gasser is a Swiss molecular biologist. From 2004 to 2019 she was the director of the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, where she also led a research group from 2004 until 2021. She was in parallel professor of molecular biology at the University of Basel until April 2021. Since January 2021, Susan Gasser is director of the ISREC Foundation, which supports translational cancer research. She is also professor invité at the University of Lausanne in the department of fundamental microbiology. She is an expert in quantitative biology and studies epigenetic inheritance and genome stability. Recipient of multiple swiss and European awards, she was named member of the US Academy of Sciences in 2022.

<span class="mw-page-title-main">Nevan Krogan</span> Canadian molecular and systems biologist

Nevan J. Krogan is a Canadian molecular and systems biologist. He is a professor and the Director of the Quantitative Biosciences Institute (QBI) at the University of California San Francisco (UCSF), as well as a senior investigator at the J. David Gladstone Institutes.

Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.

Walter Wahli, born on 23 May 1946 in Moutier, Switzerland, is a distinguished biologist and professor. He has held academic positions at the University of Lausanne and at Nanyang Technological University of Singapore. Wahli's research has contributed to the understanding of metabolic regulation through gene expression. He is particularly recognized for his work on nuclear receptors, specifically the Peroxisome proliferator-activated Receptors (PPARs), which play a crucial role in regulating the body's energy balance.

<span class="mw-page-title-main">Cathrin Brisken</span> German and Swiss cancer researcher

Cathrin Brisken is a German and Swiss medical doctor, researcher, and professor at the École Polytechnique Fédérale de Lausanne (EPFL). Her research focuses on the mechanisms of hormonal control in breast cancer development.

Niko Geldner is a German-Swiss biologist specialised in the study of Plant Cell and Developmental Biology. He is a full professor and the director of the plant cell biology laboratory at the University of Lausanne.

<span class="mw-page-title-main">George Coukos</span> Tumor immunologist

George Coukos is a physician-scientist in tumor immunology, professor and director of the Ludwig Cancer Research Lausanne Branch and director of the Department of oncology UNIL-CHUV of the University of Lausanne and the Lausanne University Hospital in Lausanne, Switzerland. He is known for his work on the mechanisms by which tumors suppress anti-cancer immune responses, and the role of the tumor vasculature in that suppression. In addition to his work in ovarian cancer, the combinatorial immune therapies proposed by Professor Coukos have been successfully tested and approved for lung, liver and kidney cancers.

Sophie Geneviève Elisabeth Martin Benton is a Swiss biologist who is Professor and Director of the Department of Fundamental Microbiology at the University of Lausanne. Her research investigates the molecular processes that underpin cellular fusion. She was awarded the EMBO Gold Medal in 2014.

References

  1. 1 2 3 "Dotto Gian-Paolo, Professor Emeritus". www.unil.ch. Retrieved 2022-10-28.
  2. 1 2 "Dotto Lab: Gian Paolo Dotto, MD, PhD". Massachusetts General Hospital. Retrieved 2022-10-28.
  3. ↑ Bock, Gregory R.; Marsh, Joan (2008-04-30). Genetic Analysis of Tumour Suppression. John Wiley & Sons. ISBN   978-0-470-51376-7.
  4. 1 2 "G. Paolo Dotto: H-index & Awards - Academic Profile". Research.com. Retrieved 2022-10-28.
  5. ↑ "PhD Programme in Cancer and Immunology". www.unil.ch. Retrieved 2022-10-28.
  6. 1 2 "International Cancer Prevention Institute | Interdisciplinary research, exchange and education in cancer prevention" . Retrieved 2022-10-28.
  7. ↑ "Nous contacter". CHUV. Retrieved 2022-10-28.
  8. ↑ Dotto, G. P.; Horiuchi, K.; Zinder, N. D. (1984-02-05). "The functional origin of bacteriophage f1 DNA replication. Its signals and domains". Journal of Molecular Biology. 172 (4): 507–521. doi:10.1016/s0022-2836(84)80020-0. ISSN   0022-2836. PMID   6607361.
  9. ↑ Bock, Gregory R.; Marsh, Joan (2008-04-30). Genetic Analysis of Tumour Suppression. John Wiley & Sons. ISBN   978-0-470-51376-7.
  10. ↑ "Academy of Europe: Dotto G. Paolo". www.ae-info.org. Retrieved 2023-03-14.
  11. ↑ "Gian Paolo Dotto, M.D., Ph.D. | Mass General Research Institute". Find a Researcher - Massachusetts General Hospital. Retrieved 2022-10-28.
  12. ↑ "ORCID". orcid.org. Retrieved 2022-10-28.
  13. ↑ "Find people in the EMBO Communities". people.embo.org. Retrieved 2022-10-28.
  14. ↑ "FBM Awards 2020". www.unil.ch (in French). Retrieved 2022-10-28.
  15. ↑ "Homepage". erc.europa.eu. Retrieved 2022-10-28.
  16. ↑ "Perspectives in Cancer Prevention | International Cancer Prevention Institute" . Retrieved 2022-10-28.
  17. ↑ "Congress of the inter-European research PhD program on Cancer Prevention – June 15 -18 2022". CANCERPREV. Retrieved 2022-10-28.
  18. ↑ "CANCERPREV - Linking knowledge, saving lives". CANCERPREV. Retrieved 2022-10-28.
  19. ↑ "studium" . Retrieved 2022-10-28.
  20. ↑ Noble, Barnes &. "Death and Resurrection: An experiment in progress|Paperback". Barnes & Noble. Retrieved 2022-10-28.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.